A personal video update from the 63 & Counting channel on six months of tirzepatide and more than 50 pounds down.
Recap by typeshit. Full story at 63 & Counting.
The EMA's CHMP amended its type 2 diabetes indication, and Italian diabetologists say Italy could be the first European country to offer the once-weekly combo.
26:19
A personal update from TakingWeightOff on life after stopping tirzepatide, three weeks in, and what caught them off guard.
Nyah Phengsitthy reports Lilly is staking out a new battlefront around an unapproved obesity treatment. The full story has the details.
A history of drug advertising, from opium-laced tonics and Radithor to the 1938 law after Elixir Sulfanilamide killed over 100 people. Semaglutide is mostly a hook.
EMY covers findings suggesting GLP-1 drugs such as Wegovy could lower the risk of certain cancers. Details on which cancers are in the full story.
Inside Retail Asia looks at skincare and aesthetic treatments brands are building for facial volume loss after rapid weight loss.
Loading…